Results 41 to 50 of about 2,077 (188)

Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review

Гинекология, 2023
The real-world treatment of genitourinary syndrome of menopause has several limitations: contraindications to topical estrogen therapy, which is currently recognized as the "gold standard" treatment for vulvovaginal atrophy (VVA), fear of the systemic ...
Mekan R. Orazov, Elena S. Silantyeva, Viktor E. Radzinsky, Liudmila M. Mikhaleva, Elizaveta A. Khripach, Evgeny D. Dolgov   +5 more
doaj   +1 more source

Ospemifene: A Novel Oral Therapy for Vulvovaginal Atrophy of Menopause [PDF]

Journal of Obstetrics and Gynaecology Canada, 2020
Vulvovaginal atrophy (VVA) resulting from estrogen deprivation at menopause often results in distressing vaginal dryness and dyspareunia. Fewer than 25% of affected women seek help for this condition citing embarrassment, cultural values, an aging or unavailable partner and concerns about use of estrogens following the Women's Health Initiative ...
Robert L. Reid, Denise Black, Christine Derzko, David Portman   +3 more
openaire   +2 more sources

The effects of royal jelly on human health: A narrative review of clinical studies

JSFA reports, EarlyView.
Abstract Royal jelly (RJ) is a natural bioactive substance with documented effects on human health. This narrative review synthesizes evidence from clinical and clinically relevant experimental studies evaluating the therapeutic potential of RJ.
Georgios Goras, Andreas Thrasyvoulou, Evanthia Tsilimpokou   +2 more
wiley   +1 more source

Potential and perspectives of local application of hyaluronic acid in vulvovaginal atrophy in women of reproductive age: A review

Гинекология
Disruption of the structure and function of the vulvovaginal epithelium in women of reproductive age is accompanied by impaired sexual function and a decrease in the quality of life.
Vera N. Prilepskaya, Niso M. Nazarova, Anastasia R. Devyatkina, Patimat R. Abakarova, Elena A. Mezhevitinova   +4 more
doaj   +1 more source

Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA

Climacteric, 2023
This study aimed to evaluate the self-reported satisfaction of Spanish postmenopausal women currently treated for vulvovaginal atrophy (VVA) symptoms.The CRETA (CRoss sectional European sTudy on Adherence) is a multicenter cross-sectional study conducted in 29 public and private hospitals in Spain, which enrolled postmenopausal women receiving ...
R. Sánchez-Borrego, M. V. de Diego Pérez de Zabalza, M. J. Alfageme Gullón, M. L. Alija Castrillo, M. Sánchez Prieto, S. Palacios, A. J. González Calvo, J. J. Quijano Martín, M. J. Cancelo   +8 more
openaire   +2 more sources

The Role of Vaginal Oestrogen Therapy in Postmenopausal Women With Pelvic Organ Prolapse: Does It Have Any Impact on Perioperative Outcomes? A Systematic Review of Randomised Controlled Trials

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Pelvic organ prolapse (POP) affects up to 50% of postmenopausal women, negatively impacting sexual function and quality of life. While surgery remains the primary treatment, increasing attention has been given to perioperative vaginal oestrogen therapy and its potential impact on surgical outcomes.
Gilda Sicilia, Salvatore Giovanni Vitale, Maurizio Nicola D'Alterio, Stefania Saponara, Francesco Scicchitano, Anna Maria Fulghesu, Rossella E. Nappi, Stefano Angioni   +7 more
wiley   +1 more source

Modern Management of the Menopause: Are We Measuring What Matters?

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Assess uptake of the Core Outcomes in Menopause (COMMA) core outcome sets (COS) and examine whether frontline treatments for vasomotor and genitourinary symptoms have been evaluated against these key outcomes. Design Methodological review. Setting Published literature and international clinical trial registries.
Joscelyn Gan, Michelle Steeper, Tim Hillard, Monica Christmas, Jan Shifren, Nick Panay, Martha Hickey, Sarah Lensen   +7 more
wiley   +1 more source

Vulvovaginal atrophy in women with and without a history of breast cancer: Baseline data from the PatiEnt satisfactiON studY (PEONY) in Italy [PDF]

Objectives: To assess clinical characteristics of postmenopausal women with moderate/severe vulvovaginal atrophy, as well as its impact on sexual function, well-being, and quality of life, and to provide an overview of most used treatments. Study design:
Villa, Paola
core   +4 more sources

Comparison of the Effect of Vitamins D and E with Conjugated Estrogen Vaginal Cream on Menopausal Vulvovaginal Symptoms: A Randomized Control Trials [PDF]

Studies in Multidisciplinary Medical Research
Menopausal vulvovaginal symptoms are common among postmenopausal women. Owing to the contraindications and limited availability of standard treatments, there is an increasing demand for alternative therapies.
Sayad Nazari, Tayyebeh Hashemi Arani, Fatemeh Sadat Asgarian, Seyed Gholam Abbas Mousavi, Zohreh Tabassi   +4 more
doaj   +1 more source

Carbon Dioxide Laser Vulvovaginal Rejuvenation: A Systematic Review

Cosmetics, 2021
Genitourinary syndrome of menopause (GSM) causes significant symptomatic aggravation that affects the quality of life (QoL). Vulvovaginal atrophy (VVA), the hallmark of GSM, is managed with topical non-hormonal therapy, including moisturizers and ...
Tassahil Messas, Achraf Messas, George Kroumpouzos   +2 more
doaj   +1 more source